Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open | $1.280 |
Close | $1.320 |
Volume / Avg. | 331.169K / 362.321K |
Day Range | 1.240 - 1.390 |
52 Wk Range | 0.650 - 2.120 |
Market Cap | $95.703M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Marinus Pharma (NASDAQ:MRNS), Alimera Sciences (NASDAQ:ALIM), Anebulo Pharmaceuticals (NASDAQ:ANEB) and Trevi Therapeutics (NASDAQ:TRVI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 4.00 expecting CLSD to rise to within 12 months (a possible 212.30% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $1.2808 last updated April 18, 2024 at 5:30 PM EDT.
There are no upcoming dividends for Clearside Biomedical.
Clearside Biomedical’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.